AID systems (a.k.a. closed-loop systems or artificial pancreas systems) currently represent the most advanced form of insulin therapy for T1D and consist of a control algorithm that automatically and dynamically drives insulin delivery from a subcutaneous infusion pump based on real-time and predicted interstitial glucose levels measured through a CGM sensor [106]. Here, INS is linked to type 1 diabetes mellitus.